MENU

RMD Stock ResMed (RMD, $281.96) was a top quarterly gainer, rising +15.27%. Expect an Uptrend reversal

A.I.dvisor
at Tickeron.com
Loading...
RMD - ResMed
3-month gain
Bearish Trend
Odds of DOWN Trend
Tickeron

Loading...

Price: $281.96
Daily change: -$3.21 (-1.13%)
Daily volume: 1M
3-month price change: +$37.35 (+15.27%)
Capitalization: $41.3B
Industry: Pharmaceuticals: Other
ResMed (RMD, $281.96) was one of top quarterly gainers, jumping +1 to $281.96 per share. A.I.dvisor analyzed 108 stocks in the Pharmaceuticals: Other Industry over the last three months, and discovered that of them () charted an Uptrend while of them () trended down. A.I.dvisor found 266 similar cases when RMD's price went up within three months. In out of those 266 cases, RMD's price went down during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for RMD are

RMD sees its Stochastic Oscillator ascends from oversold territory

On September 08, 2025, the Stochastic Oscillator for RMD moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 50 instances where the indicator left the oversold zone. In of the 50 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RMD advanced for three days, in of 348 cases, the price rose further within the following month. The odds of a continued upward trend are .

RMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 308 cases where RMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RMD moved out of overbought territory on August 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RMD as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RMD moved below its 50-day moving average on September 12, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RMD crossed bearishly below the 50-day moving average on September 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.761) is normal, around the industry mean (10.825). P/E Ratio (28.981) is within average values for comparable stocks, (56.185). Projected Growth (PEG Ratio) (1.857) is also within normal values, averaging (1.750). Dividend Yield (0.008) settles around the average of (0.016) among similar stocks. P/S Ratio (7.893) is also within normal values, averaging (14.891).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RMD showed earnings on July 31, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of devices for evaluation and treatment of sleep disorders

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9001 Spectrum Center Boulevard
Phone
+1 858 836-5000
Employees
10140
Web
https://www.resmed.com